BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
POT
Potash Corp Of Saskatchewan
POT
|
+$716M |
| 2 |
Apple
AAPL
|
+$677M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$561M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$554M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$497M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.85B |
| 2 |
Equinix
EQIX
|
+$2.31B |
| 3 |
Tesla
TSLA
|
+$2.3B |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$1.87B |
| 5 |
TRLA
TRULIA INC (DEL)
TRLA
|
+$1.64B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.77% |
| 2 | Financials | 3.07% |
| 3 | Industrials | 1.75% |
| 4 | Healthcare | 1.67% |
| 5 | Materials | 1.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Jacobs Solutions
J
$17.3B
| $1.94M | ﹤0.01% |
43,936
-26,740
| -38% | -$1.27M |
|
902
iShares MSCI Pacific ex Japan ETF
EPP
$2.26B
| $1.94M | ﹤0.01% |
39,300
-700
| -2% | -$34.7K |
|
|
DHC
903
Diversified Healthcare Trust
DHC
$2B
| $1.93M | ﹤0.01% |
80,067
-13,511
| -14% | -$316K |
|
904
iShares US Medical Devices ETF
IHI
$3.47B
| $1.92M | ﹤0.01% |
+113,190
| New | +$1.85M |
|
905
Hormel Foods
HRL
$13.4B
| $1.92M | ﹤0.01% |
77,946
-28,040
| -26% | -$678K |
|
906
Groupon
GRPN
$876M
| $1.92M | ﹤0.01% |
14,480
+11,482
| +383% | +$1.51M |
|
|
QLIK
907
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
| $1.89M | ﹤0.01% |
83,748
+70,199
| +518% | +$1.61M |
|
908
Gold Fields
GFI
$35.9B
| $1.89M | ﹤0.01% |
506,884
+252,475
| +99% | +$972K |
|
909
Patterson-UTI
PTEN
$4.21B
| $1.88M | ﹤0.01% |
53,908
+398
| +0.7% | +$13.1K |
|
|
BRCD
910
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $1.88M | ﹤0.01% |
204,613
+37,295
| +22% | +$344K |
|
911
CALL
Caterpillar
CAT
$389B
| $1.88M | ﹤0.01% |
5,067
+2,231
| +79% | +$234K |
|
912
iShares Biotechnology ETF
IBB
$9.83B
| $1.87M | ﹤0.01% |
21,879
+16,290
| +291% | +$1.28M |
|
913
CALL
Ford
F
$56.2B
| $1.86M | ﹤0.01% |
12,249
| – | – |
|
914
TransDigm Group
TDG
$69B
| $1.86M | ﹤0.01% |
11,125
+5,684
| +104% | +$1.02M |
|
915
American Airlines Group
AAL
$10.2B
| $1.86M | ﹤0.01% |
43,198
-64,694
| -60% | -$2.52M |
|
916
Wabtec
WAB
$49.9B
| $1.84M | ﹤0.01% |
22,225
+10,724
| +93% | +$827K |
|
917
Lennox International
LII
$14.8B
| $1.82M | ﹤0.01% |
20,356
+5,960
| +41% | +$518K |
|
918
Sony
SONY
$139B
| $1.82M | ﹤0.01% |
541,765
+368,520
| +213% | +$1.27M |
|
919
Ubiquiti
UI
$34.9B
| $1.82M | ﹤0.01% |
+40,165
| New | +$1.58M |
|
|
TVTY
920
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $1.81M | ﹤0.01% |
103,332
+2,935
| +3% | +$50.4K |
|
|
HBI
921
DELISTED
Hanesbrands
HBI
| $1.81M | ﹤0.01% |
73,556
-28,080
| -28% | -$579K |
|
922
CALL
Pfizer
PFE
$152B
| $1.81M | ﹤0.01% |
50,428
+34,900
| +225% | +$995K |
|
923
Core Laboratories
CLB
$569M
| $1.81M | ﹤0.01% |
10,811
+5,652
| +110% | +$1.01M |
|
924
IDEX
IEX
$17.5B
| $1.8M | ﹤0.01% |
22,336
+6,229
| +39% | +$471K |
|
925
Jabil
JBL
$37B
| $1.79M | ﹤0.01% |
85,565
-35,706
| -29% | -$664K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2014 Portfolio in Review
As of Q2 2014, BNP Paribas Financial Markets held 4,108 positions worth $106B, down 17% from $129B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BNP Paribas Financial Markets deployed $44.2B of net new capital in Q2 2014, opening 765 new positions and adding to 1,315 existing holdings. Its largest new stake was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.
By sector, the portfolio is most concentrated in Technology at 4.8% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $3.85B trimmed.
- BNP Paribas Financial Markets's largest Q2 2014 buy was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.
- BNP Paribas Financial Markets added most to Potash Corp Of Saskatchewan in Q2 2014, an estimated $716M increase.
- BNP Paribas Financial Markets's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $3.85B.
- BNP Paribas Financial Markets fully exited Walter Investment Mgt Corp in Q2 2014, selling an estimated $477M.
- BNP Paribas Financial Markets's ten largest holdings make up 42% of its $106B portfolio in Q2 2014.
- BNP Paribas Financial Markets opened 765 new positions and closed 285 in Q2 2014.
- BNP Paribas Financial Markets's portfolio value fell 17% quarter-over-quarter to $106B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2014, filed 14 Aug 2014.